Skip to main content

Table 6 Adjusted logistic regression analysis of the determinants of clinical anxiety and depression at follow-up

From: Health-related quality of life, anxiety and depression in the diagnostic phase of suspected cancer, and the influence of diagnosis

 

Anxiety

Depression

 

OR

95 % CI

p-value

OR

95 % CI

p-value

Baseline global QL

0.98

(0.96; 0.99)

0.01

0.99

(0.97; 1.00)

0.06

HADS Anxiety at baseline

 Score <8

Reference

Reference

 Score ≥8

9.80

(5.79; 16.60)

<0.001

1.63

(0.92; 2.89)

0.09

HADS Depression at baseline

 Score <8

Reference

Reference

 Score ≥8

1.31

(0.71; 2.43)

0.39

8.70

(4.70; 16.10)

<0.001

SOC at baseline

0.96

(0.93; 0.98)

<0.001

0.96

(0.94; 0.99)

0.005

Self-rated health, currently at baseline

 (very) good

Reference

Reference

 fair

1.16

(0.53; 2.54)

0.71

2.31

(0.88; 6.07)

0.09

 (very) poor

1.29

(0.59; 2.85)

0.51

2.66

(1.04; 6.78)

0.04

Co-morbidity

 0

Reference

Reference

 1

1.38

(0.74; 2.58)

0.31

1.75

(0.88; 3.46)

0.11

 ≥2

0.85

(0.42; 1.71)

0.65

2.17

(1.06; 4.45)

0.03

Follow-up post diagnosis

0.49

(0.27; 0.88)

0.02

1.02

(0.54; 1.96)

0.94

  1. Non-significant predictors including age, gender, SRH compared to 3 months ago at baseline, cancer diagnosis (yes/no), marital status, education, occupation, previous cancer in patient and hospital were excluded from the table. McFadden’s R 2 = 0.37 for anxiety model and 0.38 for depression model. Hoswer and Leweshow test was 0.56 for both models
  2. Significant results are highligthed in bold